Metabolic gene polymorphism frequencies in control populations.Seymour Garte, Angela Risch, Simone Benhamou et al.|PubMed|2001Cited by 847
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperBernhard Wörmann, Ralf‐Dieter Hofheinz, Carsten Bokemeyer et al.|Oncology Research and Treatment|2020Cited by 88
Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE Genetic Susceptibility to Environmental Carcinogens pooled analysisEmanuela Taioli, Ping Yang, Simone Benhamou et al.|Genetics in Medicine|2007Cited by 52
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistanceTheresa Klümper, Ingolf Cascorbi|Experimental Hematology and Oncology|2020Cited by 36